The optic nerve is made of highly specialized neurons and the energetic supply to their axons is crucial due to their great demand. The energy comes basically through the oxidative phosphorylation in the mitochondria, supported by glial cells metabolism. Mitochondrial dysfunction is a shared feature encountered within the optic neuropathies, including Leber's Hereditary Optic Neuropathy, Leigh's Syndrome, or Kjer's syndrome.
Introduction
The nervous system includes a great variety of cell types (among others: astrocytes, neurons, and oligodendrocytes), what makes one of the most complex tissues in the human body. The correct metabolic linkage between these cell types is key to allow the central nervous system (CNS) circuits' physiological performance. The optic nerve is the main myelinated neural tract in the CNS, and it is a Our laboratory counts on a mutant mouse which shows an impairment of the metabolic network that connects cell types within the CNS. Therefore, this mutant mouse makes a powerful tool in order to study neurologic and metabolic diseases.
In this work, we present a metabolomics-based study in the optic nerve of Mice with Neurological Visual Disease (NVD) compared to wild-type animals.
Over the past decade, metabolomics, which attempts to detect, quantify and identify the widest possible range of metabolites integrating the metabolome of biological fluids, tissues, and cells, has proven to be a useful tool for several applications, including unveiling potential biomarkers for clinical diagnostics, studying the mechanism under different pathologies, pharmacological treatments, and environmental effects in different organisms, among others [2] . This is possible since the metabolites reflect the final products that different cellular and regulatory processes leave behind, providing a snap shot of the set of all these processes occurring at a specific moment. Despite the fact that a classification of different strategies for metabolomic studies was proposed [3] , the two mainly approaches employed in this field nowadays are the targeted and untargeted analysis. Targeted metabolomics is intended for the quantitative measurement of a predefined set of metabolites normally involved in a specific pathway or metabolic reaction. On the other hand, untargeted metabolomics scope is the analysis of as many metabolites as possible present in a biological system to identify novel pathophysiological pathways and uncover biomarkers [4] . The detection of all the mechanistic insights in a biological sample has been greatly strengthened thanks to the remarkable improvement of the analytical platforms available and the development of new powerful bioinformatics tools [5, 6] . Analytical techniques based on mass spectrometry show extremely high potential in metabolomics and, in particular, the application of GC-MS platform provides high separation efficiency allowing the detection and quantification of metabolites involved into the central metabolic pathways, including amino acids, short and long chain free fatty acids, cholesterol, among others. All of them are low molecular weight compounds that can be converted into their volatile derivatives [7] .
The optic nerve presents a great content of a wide variety of lipids classes, ranging between 50 to 60% of its dry weight, located in the myelinated and unmyelinated nerve areas, connective tissue, glial cells, and blood vessels [8] . It also contains a high concentration of cytoskeletal proteins, considering neurofilaments, microtubules, microtubule associated proteins (MAPs), and actin as the principal constituents of the neuronal cytoskeleton, which confers a special hardness to the tissue [9] . Metabolomics-based studies of the optic nerve are scarce and mainly focused on the lipid composition [10, 11] and almost absent on the investigation of polar and small metabolites.
Based on the evidences previously described, GC-MS was the configuration selected for the development and validation of a method for the absolute quantitation of lactic acid and pyruvic acid in optic nerve tissue samples of a mutant mice model and its corresponding control group (wild-type, WT), followed by an untargeted metabolomics approach and the characterization of the metabolic profile of the optic nerve.
Materials and methods

Samples
Mice were housed in specific pathogen-free conditions, humidity and temperature-controlled room on a 12-h light/dark cycle, receiving water and food ad libitum. All animal procedures were approved by the corresponding institutional ethical committee (CBMSO) and were performed in accordance with Spanish and European directives. All efforts were made to minimize animal suffering. Samples were obtained from four months WT and NVD mutant mice. After cervical dislocation, we proceeded with the immediate extraction and freezing of the optic nerves in liquid nitrogen.
Reagents
Lactic acid 98%, pyruvic acid 98%, pentadecanoic acid 99%, and methyl stearate standards 99% were purchased from Sigma-Aldrich (Steinheim, Germany). Reagents for derivatization (O-methoxyamine hydrochloride and BSTFA:TMCS, 99:1 (Sylon BFT)) were purchased from Sigma-Aldrich and Supelco (Bellefonte, PA, USA), respectively. Two standard mixes for GC-MS, one containing grain fatty acid methyl esters (C8:0-C22:1, n9) and another standard mix with a mixture of n-alkanes (C8-C40) and analytical grade heptane were purchased from Fluka Analytical (Sigma-Aldrich Chemie GmbH, Steinheim, Germany). Silylationgrade pyridine was from VWR International BHD Prolabo (Madrid, Spain). HPLC grade methanol was obtained as well from SigmaAldrich.
Working solutions and standards for method validation
Individual stock solutions of lactic acid, pyruvic acid, pentadecanoic acid (IS), and methyl stearate (IS) were prepared in methanol and stored at −20 • C. From these solutions, an intermediate solution of each compound was prepared and stored at 4 • C during the working week and these solutions were appropriately diluted on the day of the analysis.
Sample treatment and GC-MS analysis
Sample preparation for GC-EI-Q-MS analysis was performed at CEMBIO (Madrid, Spain). Eight optic nerve samples from a mutant model (NVD) (n = 4) and wild-type (WT) (n = 4) mice, and 18 samples (NDV, n = 9, male/female 5/4; WT, n = 9, male/female 4/5) were selected for validation of the method for target analysis of lactic acid and pyruvic acid and for non-targeted metabolomic studies respectively. All samples were stored at −80 • C and the day of the analysis they were defrosted, followed by the addition of 100 L of cold methanol (−20 • C) containing the internal standard (IS) pentadecanoic acid (25 ppm) . This compound has been previously used as an IS for targeted and untargeted metabolomics-based studies by GC-MS with satisfactory results [12] . Then, samples were homogenized using a 2 mm particle size glass beads for the TissueLyser LT homogenizer (Qiagen, Germany), and placing samples on ice in between of TissueLyser cycles for 30 s, 6 times each. The extracted samples were then centrifuged at 13.000g at 4 • C for 10 min. For the validation of the method, all the supernatants (80 L) were pooled, and then frozen at −80 • C, while for the metabolomics analysis, 80 L of the supernatant of each sample was transferred into a GC-MS vial.
Afterwards, samples were chemically derivatized for GC-MS analysis. The 80 L of supernatant previously collected were evaporated to dryness using a SpeedVac Concentrator System. Methoxymation was performed by adding 20 L of O-methoxyamine hydrochloride (15 mg/mL in pyridine) to each sample and vigorously vortex-mixed for 5 min. Then, vials were incubated in darkness at room temperature for 16 h. For silylation process, 20 L of BSTFA:TMCS (99:1) were added, vortex-mixed for 5 min, and capped vials were placed in the oven at 70 • C for 1 h. Prior to injection, 100 L of heptane containing C18:0 methyl ester (10 ppm) as instrumental IS was added and again vortex-mixed for 1 min to dissolve derivatives. Two blank solutions were prepared along with the rest of samples following the same procedure of extraction and derivatization and analyzed at the beginning and at the end of the sequence.
Quality control samples (QC) were prepared by pooling equal volumes (approx. 20 L) of optic nerve homogenate from each of the 18 samples prior to the derivatization process. Four QC samples were independently prepared simultaneously with the study samples by dividing up the total volume of this pooled QC. In order to measure the performance and stability of the system together with the reproducibility of the sample treatment procedure, QC samples were analyzed every 6 samples throughout the run.
A flowchart of the method procedure for the GC-MS analysis of the optic nerve tissue samples is presented in Fig. 1. 
Targeted and non-targeted fingerprinting of mouse optic nerve
Samples were prepared according to the previous extraction method and analyzed by GC-MS for targeted and non-targeted metabolomics analyses following the method described below. With the targeted approach, the absolute quantitation of lactic acid and pyruvic acid in optic nerve samples was performed by means of authentic analytical standards and with the non-targeted approach the metabolite profile was characterized.
Optic nerve analysis by GC-MS
The analysis of the derivatized extracts was performed with a GC instrument 7890A from Agilent Technologies (Waldbronn, Germany) coupled to an inert mass spectrometer with triple-Axis detector 5975C (Agilent Technologies). The injection volume of derivatized samples was set at 2 L using an autosampler 7693 (Agilent Technologies). Samples were automatically injected in split mode, with a split ratio 1:10, into an Agilent deactivated glass wool split liner. Separation of the compounds was achieved using a 10 m J&W pre-column (Agilent Technologies) integrated with a 122-5332G column: DB5-MS 30 m length, 0.25 mm i.d. and 0.25 m film consisting of 95% dimethyl/5% diphenyl polysiloxane (Agilent Technologies). Helium was used as the carrier gas with a constant flow rate of 1 mL/min. The lock of the retention time (RTL) relative to the internal standard (methyl stearate C18) peak at 19.66 min was performed. The chromatographic separation consisted on temperature gradient for the column oven programmed at 60 • C (maintained for 1 min), then raised by 10 • C/min until it reached 325 • C, and was held at this temperature for 10 min before cooling down. The injector and the transfer line temperatures were set at 250 • C and 280 • C, respectively. MS system: the electron impact ionization operating parameters were set as follows: filament source temperature, 230 • C; electron ionization energy, 70 eV. Mass spectra acquisition range was set at 50-600 m/z at a scan rate of 2 spectra/s. For retention index determination, a mixture of nalkanes (C8-C40) and a mixture of FAMEs (C8:0-C22:1, n9) were run prior to the samples. Data were acquired using the Agilent MSD ChemStation Software (Agilent Technologies).
GC-MS data treatment
Total ion chromatograms (TICs) obtained after the analysis were inspected based on both quality of the chromatograms and internal standard signals. First, samples were processed with MassHunter Workstation GC/MS Translator software version B.04.01, in order to made them compatible with the MassHunter Quantitative data analysis version B.08.00. The resulting data files were exported to Agilent MassHunter Unknowns Analysis Tool 7.0 for the deconvolution process and metabolite identification of raw data collected by GC-MS analysis. In order to obtain a chemical identity for the compounds, the software executed a search against two target libraries: Fiehn library version 2008 and the CEMBIO in-house spectral library and always by comparing both retention time (RT) and spectra extracted during the deconvolution against each compound included in the library. For the non-identified compounds, a mixture of n-alkanes, that was analyzed at the beginning of the analytical run, was used as reference for RT/RI comparison with a commercial spectral library -NIST (National Institute of Standards and Technology) library 2.2 version 2014. Those metabolites with spectrum score higher than 80% and concordant retention index based on the n-alkane scale were putatively identified according to NIST. Data obtained by the Unknown Analysis Tool were aligned using MassProfiler Professional B.12.1 (Agilent Technologies). Then, Agilent MassHunter Quantitative Analysis version B.08.00 was used for the assignment of the target and qualifiers ions and peak area integration. Prior to the statistical analysis, sample areas were normalized by pentadecanoic acid (IS) abundance in order to minimize the response variability coming from the instrument, and then each sample was normalized by the amount of protein per optic chiasm, expressed in micrograms (g). Finally, data were filtered by the coefficient of signal variation (CV) in QCs, considering as acceptable values lower than 30%.
Statistical analysis 2.8.1. Targeted metabolomics
After the analysis, data were collected and reprocessed as previously described, followed by the univariate statistical analysis (UVDA). For this purpose, the normality of data was assessed by Shapiro-Wilk test and then Studentís t test (p ≤ 0.05) using MATLAB (R2015a, MathWorks), with unpaired unequal variance assumed, was performed, to determine whether the mean values of the two groups were different for lactic acid and pyruvic acid. Finally, in order to control the false discovery rate at level a = 0.05, Benjamini-Hochberg correction test were employed [13] .
Non-targeted metabolomics
To investigate differences in the global profile between the groups, both univariate (UVDA) and multivariate data analysis (MVDA) were assayed. The UVDA was performed following the same statistical approach as for targeted metabolomics, to test each individual metabolite in the samples. For MVDA, processed data were imported into SIMCA version 14 (Umetrics, Umeå, Sweden). Initially, unsupervised principal component analysis (PCA) plot was applied considering all samples from both groups including QC samples to observe the natural grouping of samples and verify the clustering of QCs, revealing the robustness and stability of the analytical procedure. In order to investigate the compounds that account for the PCA separation, supervised partial least square discriminant analysis (PLS-DA) model was plotted. Finally, OPLS-DA models for the comparison were obtained. The fitness and prediction capabilities of each model were assessed by the explained variance (R 2 ) and the predicted variance (Q 2 ), respectively, supplied by the software. Finally, statistically significant variables were selected on the basis of the variable importance in the project (VIP) value and jackknifing confidence interval resulting from the OPLS-DA model [14] . Since OPLS-DA method has a high tendency to over-fit models to the data, the model built was obtained was validated applying cross-validation strategy in order to avoid the risk of overfitting and test the predictability of the statistical model, leaving 1/3 of the samples out per group and calculating the percentage of samples correctly classified into their respective groups [15] .
Validation study
The method for extraction and quantitation of lactic and pyruvic acid in optic nerve samples was validated in terms of selectivity, linearity, limits of detection and quantitation (LOD and LOQ, respectively), recovery, instrumental precision and method precision (both with standards and samples) for GC-MS platform.
Linearity, LOD and LOQ
The linearity of the relative response for standards was tested based on the three replicates of six different concentration levels of standard solutions, covering the expected values oscillating between 10% and 200% of mean values obtained in preliminary measurements with real samples.
The LOD and LOQ were determined at the lowest concentration point of linearity by using signal-to-noise ratio (S/N) > 3 and 10, respectively.
Recovery
The recovery of the two analytes was evaluated with samples spiked with known standard solutions. This parameter was tested at four different levels of concentration (50%, 100%, 150%, 200%) and the analysis was repeated three times for each concentration. The regression coefficients of these standard addition calibrations were calculated. Besides the recovery of the analytes was reported by comparing the added concentrations with the experimental ones.
Precision
The instrumental precision of the method was evaluated based on the consistency of instrumental response for a given analyte in the midrange of the calibration curve. It was calculated by consecutive injections (n = 10) of a homogeneous standard solution. The intra-day precision of the method was assessed by injecting individual preparations of standards and samples (n = 7 and n = 6, respectively) in the midrange of the calibration curve. Inter-day (n = 12) precision was tested in the same way, but repeating the experiment on a different day, with a new non-defrosted optic nerve pool.
Results
Method validation
The main objectives of this study were the development of a method for the absolute quantitation of lactic and pyruvic acid in optic nerve tissue samples and to validate the method as a robust, sensitive, and reproducible along with the characterization of its metabolic profile by GC-MS technique. During the validation process, the correlation coefficients obtained fitted the linear model (r ≥ 0.990) for both metabolites and no bias was found for lactic acid since the confidence limit calculated for the intercept included the zero but for pyruvic acid slight bias was found due to the lower variability of the data and without further consequences.
Recoveries were 100.4% for pyruvic acid and 106.9% for lactic acid, with a RSD of 6.6% and 6.5%, respectively (n = 12). For standards, instrumental precision (n = 10) was tested for a constant response of IS and were 1.2% to 3.4% respectively. Intra-day precision for standards (n = 7) ranged from 3.4% to 6.4%. RSD for intra-day precision were calculated by analyzing the same assay 6 aliquots independently prepared from the pool of sample. The daily RSD ranged from 5.9% to 7.3%, and the values obtained in the inter-day precision study were from 6.1% to 9.5% in different days (n = 12).
For each compound, the theoretical LOD calculated based on the IUPAC method ranged from 2.5 × 10 −4 mM in solution equivalent to 0.012 g/sample, and the LOQ was in the range 8.4 × 10 −4 mM equivalent to 0.042 g/sample. These values were found to be lower than the lowest value of their respective range of standards. All these validation parameters and their results are summarized in Table 1 .
Targeted metabolomics
The validated extraction method for quantitation of lactic acid and pyruvic acid in optic nerve tissue by GC-MS was employed for the absolute quantitation of these two metabolites in the 18 samples corresponding to the NVD mice group (n = 9) and WT group (n = 9).
For this purpose, linear regressions were assayed for both metabolites using pentadecanoic acid as IS covering the range of expected concentration values. The linearity of each analyte standard was evaluated, obtaining a correlation coefficient, r > 0.997 and r > 0.995 for lactic acid and pyruvic acid, respectively. After the univariate statistical analysis for the comparison of the two groups, the p values obtained for lactic acid and pyruvic acid were 0.0049, and 6.48 × 10 −4 , respectively resulting statistically significant their differences. These results are represented in Fig. 2 . 
Non-targeted metabolomics
For the non-targeted metabolomics approach, the method was employed for the analysis by GC-MS of the optic nerve samples belonging to the NVD group (n = 9) and WT group (n = 9).
After GC-MS analysis and data pretreatment, 109 entities were obtained after deconvolution, and alignment and after data normalization and filtering, 79 of them were annotated compounds with RSDs below 30% in the QC samples. This data set was used for further analyses. Concerning to the robustness of the methodology, the initial PCA plot showed the QC samples tightly cluster, determining the stability and reproducibility of the system. PLS-DA plot showed that samples have a clear tendency to gather into their respective groups, suggesting that the metabolites levels change due to the mutation present in the NVD group respecting the WT group. These differences were evaluated by an OPLS-DA model. Regarding to the quality of the multivariate models obtained, PCA plot presents a quality of variance explained and predicted vari- Range (g/sample) 0.135-2.027 1.9 × 10 −3 -3.9 × 10 Additionally, univariate statistical analysis was performed simultaneously with multivariate statistical analysis, and on the basis of the VIP threshold (VIP ≥ 1), jackknifing confidence interval not including 0, and the Student's t test p value (p < 0.05) corrected by Benjamini-Hochberg test, 34 metabolites were found as statistically significant when comparing NVD vs WT. Finally, fold change was calculated for each metabolite to evaluate the positive or negative trend of their levels regarding to the control group. As it can be observed in Table 2 , an overall positive trend was found in all the metabolites obtained after both statistical analyses.
Characterization of the metabolite profile
Chromatographic profiles obtained after GC-MS analysis were characterized by using the standard "Fiehn metabolomics retention time lock (RTL)" method. At the end of the process, 94 peaks were assigned to the optic nerve profile. Amino acids, carboxylic, dicarboxylic, and tricarboxylic acids, hydroxy acids, pyrimidines, purines and purine nucleosides, sugars, cholesterol, amines, carbohydrates, and fatty acids, among other metabolite classes can be distinguished across the profile. Most of the metabolites identified were derived from the endogenous metabolism of the optic nerve tissue, and are known to be involved in several metabolic pathways. Cholesterol can be observed as the highest peak in the Total Ion chromatogram, followed by myo-inositol. Cholesterol is present at high levels in the nervous system as the major architectural component of compact myelin. It is the precursor of several oxysterols, steroid hormones, and bile acids. Lipid composition of nervous tissues ranged from 50% to 60% of their dry weight. Together with cholesterol, different fatty acid classes were detected through the chromatographic profile, divided in saturated fatty acids (SFA) caproic acid (C6:0), palmitic acid (C16:0), stearic acid (C18:0), and arachidic acid (C20:0); monounsaturated fatty acid (MUFA) oleic acid (C 18:1 cis-9); and polyunsaturated fatty acids (PUFA) including linoleic acid (C18:2 -6), and arachidonic acid (C20:4 -6). Regarding to myo-inositol, the second highest peak in the chromatogram, serves not only as a precursor molecule for inositol-containing lipids, but also as an important osmolyte. It is considered as glial cell marker and its presence as a free form is higher in nerves than in any other tissues [16] . Fructose and mannose are considered as alternative energy substrates. Optic nerve tissue can supply a glucose deficit with these two sugars to achieve the generation of compound action potentials (CAPs) [17] . Along with cholesterol and myo-inositol, acetoacetate, lactic acid, phosphoric acid, leucine, and glycerol peaks also domain the profile. Some of the compounds here described have been previously reported in human, rat, and mouse optic nerve tissue by different analytical approaches [18] [19] [20] , but to our knowledge, this is the first time that the whole metabolomic profile of mouse optic nerve has been characterized by GC-MS analysis. The 94 compounds assigned along the TIC obtained after the GC-MS analysis are presented in Fig. 4 and Table 3 . Additionally, Fig. 5 represents the spectra of the metabolites glycerol 1-phosphate and 1-monopalmitin obtained after GC-MS analysis against their recorded spectra in Fiehn and NIST libraries, respectively.
Metabolic pathway analysis
Once the method for the analysis of optic nerve samples by GC-MS was validated and then used for the non-targeted metabolomic study, the visualization and interpretation of the connections among the 34 metabolites resulted as statistically significant through their metabolomic networks were achieved using MetScape, a plug-in of Cytoscape [21] . The metabolomic network obtained remarks the main metabolic interconnections, resulting in an integration of the metabolomic experimental results with biological knowledge [22] . In this way, the principal metabolic pathways affected by the NVD mutation presented in the optic nerve tissue were easily identified. The organism selected in the KEGG database included in the software was Mus musculus, aiming to increase the specificity of the results. In Fig. 6 , the dark red hexagons represent the significant metabolites obtained in our analysis, while the light red hexagons were designated to the intermediary metabolites that are known to be involved within each metabolic reaction, connecting through them the different metabolic pathways that resulted affected. Additionally, according to the altered metabolites listed in Table 2 , a quantitative enrichment analysis (QEA) was built with MetaboAnalyst 3.0 (http:// www.metaboanalyst.ca) to distinguish whether any certain identified pathway is more represented than the others, based on their p values and the fold enrichment. The ratio of altered metabolites and the total number of metabolites involved in the pathway are also represented in the table supplied [23] .
The interconnections of 26 metabolic pathways are represented in the metabolomic network graphic, including Bile acid biosynthesis, ␤-alanine metabolism, Galactose metabolism, Glycerophospholipid metabolism, Glycine, serine, alanine and threonine metabolism, Glycolysis and Gluconeogenesis, Glycosphingolipid metabolism, Methionine and cysteine metabolism, Pyrimidine metabolism, Squalene and cholesterol biosynthesis, TCA cycle, Urea cycle, Arginine, proline, glutamate, aspartate and asparagine metabolism, Valine, leucine and isoleucine degradation, among others.
However, 22 metabolite sets were enriched in the optic nerve tissue of NVD mice group comparing with the WT group, with a pFDR < 0.05, considering just pathways matching more than 2 metabolites in the pathway (Table 4) . Based on the results reflected in the quantitative enrichment analysis, the most enriched pathway related to the NVD mutation is the pyrimidine metabolism (pFDR = 0.0014), counting with 4 altered metabolites of its 36 total compounds, together with the galactose pathway (pFDR = 0.0014), with 2 of the 25 compounds that are integrated in this pathway. Additionally, different enriched metabolic pathways can be found in the table, as the urea cycle (pFDR = 0.0076) with 7 of the 20 compounds that conform this cycle, followed by arginine and pro- line metabolism (pFDR = 0.0076) with 6 enriched metabolites of its 26. Alanine, glutamic acid and pyruvic acid encompass the 50% of the metabolites that form the alanine metabolism (pFDR = 0.0076), and together with the protein biosynthesis (pFDR = 0.0076), which presents a 63% of its metabolites altered, are also strongly affected in the optic nerve metabolism due to the mutation present in these mouse model.
Discussion
Optic neuropathies represent an important cause of acute to chronic visual impairment and blindness. Alterations in the metabolism of the neural system lead to serious visual-neurologic pathologies such as Leber's Hereditary Optic Neuropathy, Kjer's syndrome, Friederich Ataxia or Leigh's Syndrome [24] . A common feature presented in the pathophysiology of these diseases is the genetic or acquired mitochondrial dysfunction, which produces the selective loss of retinal ganglion cells (RGCs) and contributes to the optic nerve degeneration. Mitochondria produce energy from different substrates; thus, the accumulation of energy substrates, including pyruvic acid, branched-chain amino acids (BCAAs), and fatty acids, and their by-products such as alanine, ornithine, or lactic acid that we observed in this NDV mice model might indicate a mitochondrial dysfunction.
The optic nerve is the principal myelinated tract of the Central Nervous System (CNS) and is formed by two different types of cells: neurons, excitable cells responsible for the transmission of the nerve impulse and glial cells (astrocytes, oligodendrocytes, microglia), that confer mainly metabolic support to neurons [25] . In a certain way, a correct metabolic coupling between oligo- Table 3 Compounds designated along the TIC of the optic nerve tissue by GC-MS.
COMPOUND NAME RT (min) COMPOUND NAME RT (min) COMPOUND NAME RT (min) dendrocytes, astrocytes and neurons is necessary for the proper functioning of the neural circuits in the optic nerve [26] . Specifically, two essential metabolites for the appropriate optic nerve function are lactate and pyruvate. Physiologically, neurons transform lactate into pyruvate and degrade it in the mitochondria in order to obtain energy. Therefore, alterations in neuronal and glia metabolism lead to an imbalance in the levels of lactate and pyruvate in neuronal circuits. Thus, the unavailability of energy production among the cell types could explain the accumulation of lactate and pyruvate in our mutant mouseís optic nerve due to the incapacity of them being degraded, thus causing a pathological condition.
Regarding to the enrichment of amino acids such as alanine, glycine, threonine, serine, phenylalanine and leucine suggests an increase in protein catalysis, possibly due to their oxidation. This correlates with the high measures of aminomalonic acid and hypotaurine, both seen in stress-like situations induced by mitochondrial dysfunction [27] .
Valine, leucine, and isoleucine are the three essential BAAs. The transport of these three metabolites, together with other amino acids (phenylalanine, tryptophan, methionine, tyrosine, histidine, and threonine) into the brain and other organs is possible through the presence of the L1-neutral amino acid transporter (LAT1) [28] . In consequence, amino acid uptake by the brain and the neurotransmitters synthesis will be determined by the relative concentration of each amino acid and the competition among them for the same transporter. In fact, Leu plays a key role in mammals' metabolism. Neurons need a constant supply of glutamate, which is oxidized not only by neurons but also by the glia cells. BCAAs, and in particular Leu, are a source of nitrogen donors (-NH 2 ) for glutamate synthesis [29] . The deamination of Leu, which is obtained from the blood stream, takes place mainly in the astrocytes, leading to glutamate. Then glutamate is converted into glutamine through the action of the enzyme glutamine synthetase (GS), which is the major glutamate-forming enzyme located in astroglial cells and also plays a critical role in the ammonia assimilation [30] . Then, when glutamine is transported to the neurons, can be transformed to glutamate to close the metabolic route. In consequence, one molecule of ammonia is released and must be transported back to the astrocyte for the detoxification process. If the mechanism of recycling ammonia is not working properly and gets accumulation in neuronal tissue, it might cause neurotoxicity by affecting metabolic pathways of several amino acids including neurotransmitters, and can induce oxidative stress, alterations in the nitric oxide synthesis, mitochondrial permeability transition and signal transduction pathways. These events might induce neuronal loss, axonal impairment and deficiency of dendritic growth [31] . A deficiency in the activity of the enzyme GS could explain the alterations observed in the glutamate metabolism pathway and in the ammonia recycling process displayed by the QEA, together with the accumulation of urea in the optic nerve. The increment of creatinine levels could be explained as consequence of the up- regulation of several metabolites involved in the urea cycle, from which this metabolite derives. Additionally, an increment of glycine was detected and it is linked with urea and creatinine through the creatine/creatinine metabolism and its coupling to the urea cycle and the catabolism of l-arginine and l-ornithine. The urea cycle is one of the pathways involved in the detoxification process of ammonia [32] . It involves a set of biochemical steps in which nitrogenous waste products coming from protein and amino acid breakdown are removed by their conversion into urea. Citrulline and aspartic acid are substrates also for urea synthesis, giving fumaric acid, and ornithine as intermediate metabolites. Fumaric acid is directed into the citric acid cycle, while ornithine will be the starting point for the synthesis of other metabolites found altered in this study, including glutamate.
Therefore, we hypothesize that in order to keep physiological energy levels, the optic nerve cell needs to modify its metabolism degrading proteins and so generating the observed amino acid excess. As a consequence of the degradation of proteins, urea is over-generated (and also ornithine and other intermediate metabolites). The connection between these metabolic pathways is represented in Fig. 7 .
Additionally, N-acetyl-aspartate (NAA), an acetyl group donor from aspartic acid, was also increased in NVD mice. This metabolite is present at high concentrations in the neuronal tissue of brain mammals, being second only to glutamate in terms of the free amino acid derivative. However, it is practically undetectable in other tissues [33] . It is located predominantly within the cellular matrix in the nerve cells. The enzyme responsible for its synthesis, the N-acetyl transferase, is exclusively present in nervous tissue, more specifically, in the mitochondrial fraction [20] . On the other hand, the enzyme in charge of its degradation, the aspartoacylase (ASPA), has been found expressed only in oligodendrocytes [34] . Despite of the fact that its role still remains unclear, it is suggested that NAA, together with NAAG, is involved in cellular signaling mechanisms and plays a key role in the regulation of the brain cells interconnections and the maintenance of the nervous system. NAA could also indicate the neuronal viability in many neurodegenerative diseases, including axonal pathologies [20] . The increased levels of NAA in the optic nerve tissue could be produced by a reduction of the catabolic enzyme activity, and this might lead to a demyelination process, which is a common feature in the Canavan disease (CD). The NAA increment can also generate an up-regulation of nitric oxide levels causing oxidative stress, genotoxicity and protein interaction, that contribute to neurodegenerative processes [35] . Additionally, since NAA is synthesized in the mitochondria, its increment could be also explained by the higher levels of pyruvic acid present in the optic nerve of NVD mice, since this relationship has been previously described in mitochondria from brain rats [36] .
Conclusions
A sensitive, rapid, and simple one single-phase method for the extraction and analysis of metabolites in optic nerve tissue samples by GC-MS is presented. The method was validated for the quantitation of two specific metabolites, lactic acid and pyruvic acid, in terms of linearity, recovery, sensitivity, and precision Based on our results, the method was found to be reliable for the targeted and non-targeted metabolomics analyses of the optic nerve samples. The whole metabolite profile has been characterized and 
